Author:
Chakrabarti Subhadeep,Wu Jianping
Publisher
Public Library of Science (PLoS)
Reference75 articles.
1. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III);JI Cleeman;Jama-Journal of the American Medical Association,2001
2. Coppack S, Mohamed-Ali V, Karpe F (2005) Metabolic Syndrome: Insulin Resistance, Obesity, Diabetes Mellitus, Hypertension, Physical Activity and Genetic Factors. Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors: 22–49.
3. The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology;MV Potenza;Nutrition in Clinical Practice,2009
4. The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?;A Karagiannis;Expert Opinion on Therapeutic Targets,2007
5. Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology;L Sgarra;American Journal of Physiology-Endocrinology and Metabolism,2012
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献